ArticleOncogene2019

HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases.

Gabriela Paroni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.